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871 Atrial Tachycardia and Fibrillation. 
Anatomic, Cellular, and Molecular 
Considerations 
Tuesday, March 19, 2002, 4:00 p.m.-500 p.m. 
Georgia World Congress Center, Room 16OW 
4:00 p.m. 
871-I A Novel Index Reveals Dual Pathway Conduction 
During Atriai Fibrillation 
BZhano. Kent A. Mowrey, Saroja q  harati, Todor N. Mazgalev, The C/eve/and 
Clinic Foundation, C/eve/and, Ohio, The Heart Institute for Children, Hope Children’s 
Hospital, Oak Lawn, Illinois. 
Background: The function of atrioventricular nodal (AVN) dual pathway electrophysiol- 
ogy during atrial fibrillation (AF) remains unclear. We have validated (Circulation 
2001;104:632-636) that His electrogram altemans can be used to determine which wave- 
front, the slow or the fast, reaches the His bundle. Specifically, the fast pathway (FPW) 
results in a small amplitude inferior His electrogram (IHE), while the slow pathway (SPW) 
produces large IHE. We hypothesized that this novel index can be applied during AF. 
Methods: In 6 rabbit hearts, IHEs were recorded during AF in control and after a multi- 
step surgical cut of posterior approach with subsequent morphological study. 
Results: In 5 of the 6 hearts both high and low (top panel, ‘) IHE were present, indicating 
SPW and FPW, respectively. The FPW was responsible for 47+ 24% of the conducted 
beats. In the remaining 3 hearts only SPW was operative during AF. Posterior appmach 
modification damaged only the extension of the compact node. Importantly. this revealed 
an exclusive FPW conduction in all 6 hearts (bottom panel, low IHE), and was associated 
with an increase of the average His-His interval (20+13ms vs 267a36ms. pcO.001). 
Conclusfon: We have demonstrated for the first time that HE afternans permit visualiza- 
tion of dual pathway electrophysiology during AF. While both wavefronts are important 
players, the FPW becomes dominant after SPW modification. This novel index may be a 
useful guide during clinical ablations for control of ventricular rate during AF. 
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871-3 Apoptosis in Atriai Myocytes and Bell-Upregulation in 
Ventricular Myocytes Are Transient Phenomenona in 
Persistent Atrial Fibrillation 
Richard, David Keane, Tom Aretz, Jeremy N. Ruskin, Massachusetts General 
Hospital, Boston. Massachusetts. 
Background: The cellular changes from electrical to structural remodeling in persistent 
atrial fibrillation (AF) are not all known. 
Methods: Myocardial samples from both atria and ventricles were obtained from the heads 
of 43 goats which had undergone cardiac pacemaker (4OObpm) implantation to induce AF 
in 29 goats. Goats were grouped according to AF duration, ranging from 2 to 430 days. 
Cardiac samples from the other 14 goats remaining in sinus rhythm were used as controls. 
Apoptosis was evaluated histo-and biochemically. 
Results: Persistent AF for 3 months was characterized morphologically by an up to B-fold 
increase in atdal myocyte apcptosis (TUNEL staining, 0.27 * 0.05% vs. 0.03% * O.Ol%, 
p<O.OOl) and biochemically by agarose gel electrophoresis and Western blots for Bak, 
Bcl2. Cytcchrome C. activated Caspase-3(p20); the percentage of ventricular myocytes 
labeled with Bcl2 was 5.times higher for goats in AF than in sinus rhythm (p<O.o05). The 
percentage of apoptotic atrlal myocytes. but not fibrocytes. correlated with the duration of 
AF (~~0.05). After peaks of apoptotic myocytes, atrial volume corrected by heart weight 
increased and fibrosis and glycogen deposition progressed over time (pcO.01). Goats in 
AF for 430 days revealed apoptosis in atrial and Bcl2 expression in ventricular myocytes at 
baseline levels (ns.) 
Conclusions: In this model, programmed death of myocytas increases within 90 to 120 
days of AF, despite enhanced Bcl2 expression and prior to atdal stretch and fibrosis, and 
reaches baseline levels after 210 to 430 days of AF. This transient phenomenon may con- 
tribute to the progression of electrical and structural remodeling associated with AF. 
4:45 p.m. 
871-4 Increased Open Probability of Single Cardiac L-Type 
Calcium Channels of Patients With Chronic Atriai 
Fibrillation: Role of Phosphatase 2A 
Sllaaar G. Klajg, Frank Schroder, David Vogler, Amd Schaefer, Axe1 Haverich, Bernhard 
Schieffer, Jurgen Tebbenjohanns, Helmut Drexler, Hannover Medical School, Hannover, 
Gennany 
Background: The L-type calcium channel (LCC) plays a crucial role in the electrical 
remodeling of atrial fibrillation (AF). AF is associated with reduction of L-type calcium CUP 
rent density, due to a transcriptional downregulation of LCC. However, it is unclear, 
whether this current reduction is related solely to a decrease in channel number or to 
alterations in channel function. Hence, we performed a single LCC analysis to assess 
channel gating in human AF. 
Methods: We used the cell-attached patch-clamp technique in isolated atrial human car- 
diomyocytes Of 25 patients with sinus rhythm (SR) and 15 patients with chronic AF. 
Results: On single channel level, peak average current was 1.7fold higher in AF than in 
SR, due to a 3.lfold higher open probability of LCC (table, ’ pcO.05). Since phosphatase 
2A (PPPA) is known to selectively reduce LCC open probability via channel dephospho- 
rylation, we hypothesized that PPPA expression or activity is reduced in AF. Okadaic 
acid, an inhibitor of phosphatases, increased channel open probability in SR, but not in 
AF. while western blot analysis of atrial homogenates of the same patient population 
revealed unchanged expression of PPPA. 
Conclusions: This study shows for the first time, that single LCC activity is increased in 
AF, due to an increase in channel open probability Our assessment of single channel 
data indicates impaired influence of PP2A on LCC, due to either general intracellular 
reduction of PPPA activity or impaired local interaction between PPPA and LCC in AF. 
4:15 p.m. 
871-2 Characterization of Focal Atriai Tachycardia Originating 
From Pulmonary Veins in Isolated Canine Left Atrium 
Using Optical Mapping 
Rita, Jianyi Wu, Tamana Takahashi, John Miller, Douglas P. Zipes. Jeffrey Olgin, 
lndiana University School Of Medicine, Indianapolis, Indiana. 
Background: The precise location and cellular mechanism underlying focal atrial tachycar- 
dia originating from the pulmonary veins (PVs) have not yet been completely understood. 
Methods and Results: Using optical mapping (256 mapping channels in 19 x 19 mm) in iso- 
lated canine left atrial preparations, we characterized the electrophysiological properties of 
focal PV activity induced by Isoproterenol. Based on the anatomic landmarks, definition of 
the primary PV ostium was to be between the left atrial chamber and the main PV trunk, 
the secondary ostium to be between the main PV and its branches, while the most distal 
atrial-PV junction to be between the pink atrial muscular sleeve and the white PV tissue. 
Under control conditions, in all 5 preparations, neither a PV potential nor spontaneous 
activity was observed. After exposure to 1uM of lsoproterenol for >15 min, sustained atrlal 
tachycardia at a cycle length of 447.2i12.6 me was induced in 2 preparations. Endocardial 
optical mapping showed the tachycardia to originate from a focal activity located at the pri- 
mary PV ostium. A sharp, fractionated electrogram was also recorded with extracellular 
bipolar recording from the same location as the earliest activation determined by optical 
mapping (23.2k1.6 ms earlier than the other left atrial activation). These types of electm- 
grams were not observed elsewhere in the PV during tachycardia. Overdrive pacing at a 
cycle length of 200 ms increased the tachycardia cycle length from 476.Ok2.5 ms to 
546.0a12.7 ms (p-zO.05). which was consistent with focal automaticky rather than trigger 
activity. Local ablation (with 40 W for 60 set) of the PV focus successfully eliminated atrial 
tachycardia in both preparations. There was no any spontaneous actfvfty after ablation. 
Conclusion: Spontaneous atrfal tachycardia induced by lsoproterenol in isolated canine len 
atria originated from the primary PV ostium. The mechanism underlying mis atria1 tachycar- 
dia was a focal automatic activity rather than a triggered activity or a reentry. 
Sinus Rhvthm Atrial Fibrillation 
Peak Current (fA) 16.35 i 2.34 27.25 * 4.55 
Availability (%) 36.65 f 2.96 31.75 * 3.65 
Ooen Probabilitv 1%) 3.93 * 0.44 12.30 * 1.53* 
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878 Mechanisms of Biventricular Pacing for 
Treatment of Congestive Heart Failure 
Tuesday, March 19, 2002, 4:00 p.m.-500 p.m. 
Georgia World Congress Center, Room 364W 
4:00 p.m. 
878-l Comparative Effects of Ventricular Resynchronixation 
Therapy in Patients With LV Systolic Dysfunction of 
Idiopathic or ischemic Origin 
Christophe Leclercq, Christine Alonso. Dominique Pavin, Gilles Rouault, Philippe Mabo, 
Jean C. Daubed, University Hospital, Rennes, France. 
Biventdcular pacing may improve symptoms and exercise tolerance in patients with chronic 
LV systolic dysfunction and intraventdcular conduction delay. The aim of this study was to 
compare the long-term effects of Biientncular pacing in patients with dilated cardiomyopathy 
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(EM) of iachemic origin and patients w%h idiopathic DCM. This study included 93 patients regurgitation improved by biventricular pacing in these patients with severe heart failure, 
consecuttvefy implanted with a Biventricular pacemaker between August 1994 and February atrial fibrillation and intraventricular conduction delay. 
2C00. Patients were retrospectively divtdsd into two groups (idiopathic and ischemic) accord- 
ing to the results of a recent coronary angiogram. Symptoms and objective data were 
Rand BIV 9M BIV 12M 
assessed before PM implant (pre-I) and 6 months (M-6) after. within the 2 groups. Results 
are summarized in this table : 
Conclusion : Permanent Biventrtcular pacing provides significant and sustained improvement 
in symptoms, exercise tolerance and LVEF in both idiopathtc and ischemic DCM patients. 
QRS lss**6 158*19 <0.0001 1s4t.25 15s*16 <o.ooa 1m*2 158**1 <0.0001 
duration (Rx, 
cm.5 BXIS (“) -IS*60 +53*76 <0.0001 -32i4s t&5*75 4cco1 -3rm +50*7s 0.002 
NYHA class 3.3t0.5 ho.6 ‘0.0001 3.3+0.5 2*0.5 CO.Oml 3.4ko.5 2.1iO.6 <OOOOl 
Peak"02 12*5 16*4 <0.0001 13e4 17-A O.OM)3 10*4.7 15*4 0.02 
fml.kc.min) 
LVEF ,%) 21*s 2sts oslow 2o*s as** O.W7 0008 
4:15 p.m. 
078-2 influence of Antitachy Pacing Location on the Efficacy 
of Ventricular Tachycardia Termination 
&~&&ef, Barbara Lamp, Johannes Heintze, Bert Hansky, Juergen Vogt. Frank 
Warzok, Berthold Kramm, Reiner Koerfer, Dieter Horstkotte, Hear-f Center North Rhine- 
Westphalia, Bad Oeynhausen, Germany Bakken Research Center. Maastricht, Belgium. 
Background: Biventdcular (BV) pacing is an important treatment option in patients (pts) with 
severe heart failure (HF). ICD-implantation with BV pacing is expected to help managing the 
dsk of malignant tachyarrhythmias in this population. 
Methods: The InSync ICD is a combined ICD and BV pacemaker with dual chamber detection 
and flexibte ATP programming. The InSync ICD study enrolled 81 patients with severe HF 
(93% male, 64t9 y, CAD 56%, LVEF 25+7% LVEDD 7lallmm and NYHA 2.6&6). Inclusion 
cdterta were NYHA II-IV, LVEF<35%, LVEDD>55mm and ICD indication. ICDs were randomly 
programmed to right-ventricular (RV)-ATP or BV-ATP. The VT termination efficacy and VT 
acceleration was evaluated for both padng locations and for VT cycle length (CL). 
Results: 457 spontaneous VT episodes cccurred in 26 pts. 17 pts were programmed to RV- 
ATP, 9 patients to BV-ATP. Overall ATP efficacy was 64%, with 75% for RV-ATP and 91% for 
BV-ATP. Mean VT cycle length was significantly shorter for RV-ATP (369ms YS 369ms). After 
calculation for VTCL and initial therapy using logistic regression termination efficacy remained 
signiffcantty ( 2.4 times ) higher with BV-ATP. 
Condusion: BV-ATP in this limited population appears to be more effective in VTiFVT termina- 
tion and may reduce the number of VTIFVT accelerations. 
Spontaneous Episode ATP Therapy Efficacy (FvTcFast VT Zone; vT=vT Zone) 
ATP Site 
RV 
BV 
Detection #Episodes 
FVT 50 
VT 154 
VTNFT 204 
FVT 57 
VT 170 
VTIFVT 227 
terminated 
31 (62%) 
123 (60%) 
154 (75%) 
43 (75%) 
163 (96%) 
206 (91%) 
accelerated 
15 (30%) 
5(5%) 
23 (11%) 
9 (16%) 
3 (2%) 
12 (5%) 
430 p.m. 
LVEDD (mm) 
LVESD (mm) 
MR area (cmz) 
DFf 
“=67 n=32 n=29 
7M9 66flO 66i6 
6ltlO 57fll 58i5 
10.6f13.7 6.4k6.2 5.4zt3.9’ 
346C99 357*133 405?143# 
M=months, #p=O.O6, ‘~~0.05, all compared to baseline 
4:45 p.m. 
878-4 Can the Optimum Dosage of Resynchronization 
Therapy be Derived From the intracardiac Eiectrogram? 
Angelo Auricchio, Andrew Kramer, Julio C. E&(6&. Jiang Ding, Yinghong Yu, Walter 
Hoersch, Christian Butter, Christoph Stellbrink, PATH CHF I & II investigator groups, 
Universify Hospital, Magdeburg, Aachen, Berlin, Germany, Guidant CRM, St. Paul, 
Minnesota. 
We tested the hypothesis that the degree of pre-excitation required to provide optimum 
resynchronization can be predicted from the intrinsic atrioventricular (AV) interval. Meth- 
ods: We tested 117 patients (NYHA class II-IV, EF c 30%) in the PATH CHF studies. 99 
tests in 60 patients were used in the development data set (DST) and 50 tests/37 pro- 
spective patients constitute the test data set (TST). Intrinsic AV intervals were measured 
from the atrial event to the earliest peak in the ventricular leads. Linear regression coeffi- 
cients between the AV delay that provided optimum dP/dt,, and the measured intrinsic 
AV interval were separately calculated for the cases with QRS>lSO ms 8 QRSs150 ms 
in the DST. Using these coefficients we calculated the estimated optimum AV delay for 
the cases in the TST and for all cases. The improvement in dP/dt,,, at actual optimum 
AV delay (dP/dt,& was compared with the improvement in dP/dt,,, obtained at the esti- 
mated optimum AV delay (dP/d&) both for the patients in the TST and for the entire 
population. Results: For the patients in the TST group dP/d&=.99’dP/dL,“t-1.75 
(&0.96, pcO.0001; M.03 p<O.oOOl, and i0.43 p=O.O002 respectively). For the entire 
population, depicted in the Figure, dP/d& 1 .Ol’dP/d&,-2.19 (&0.97, pc0.0001; 
to.01 and 10.26 respectively, p<O.OOOl). Conclusion: The AV delay that provides opti- 
mum dP/dt,,, can be reliably predicted from the intrinsic AV interval. 
884 
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Noninvasive Testing: Predicting Future 
870-3 Reverse Mechanical Remodeling by Biventricuiar 
Pacing in Congestive Heart Failure: One-Year Results 
From Patients in Atrial Fibrillation in the MUSTIC 
Events 
Wednesday, March 20, 2002, 8:30 a.m.-10:OO a.m. 
Georgia World Congress Center, Room 257W 
(MUltisite STimuiation in Cardiomyopathy) Study 
Cecilia Linde, Christoohe Leclerco, Serae Cazeau, Lukas KaDDenbemer, Richard Sutton, 
8:30 a.m. 
Christophe Bailleul, Jean-Claude, on behalf of the MUSTIC Study Group, 
Karolinska Hospital, Stockholm, Sweden. 
Background: The MUSTIC study is a controlled multicenter trial, to assess the clinical 
efficacy of biventdcular pacing @IV) in patients with chronic NYHA ill heart failure and 
intrinsic QRS >150 or RV paced QRS >200 ms. We recently reported symptomatic relief 
from the crossover phase (CO) with progressive improvements over a year. The aim of 
this study was to assess if left ventricular function improves over time in the group of 
patients with atrial fibrillation (AF) and slow ventricular rate either due to spontaneous 
rhythm or His-ablation. 
Methods: Of 64 included patients 39 completed the 6 month CO single blind comparison 
of BIV and no-BIV excluding two patients who due to fast AF were not BIV paced. Of 
these 35 preferred and were programmed to BIV and followed longitudinally by clinical 
parameters, Doppler echocardiography and left ventricular (LV) ejection fraction mea- 
sured by radionucleides. 
Results: LV ejection fraction increased from 26.7 * 6.6 % at randomisation (rand) to 30.4 
i: 7.6 % after 1 year of BIV (p<O.O5). LV function by Doppler echo i.e. diastolic filling time 
(DFT), left ventricular enddiastolic and systolic diameters (LVEDD, LVESD) and mitral 
regurgitation (MR) are given in the Figure. 
Conclusion: In parallel with clinical benefits, left ventricular ejection fraction and mitral 
884-l Value of Immediate Postoperative Electrocardiogram to 
Readjust Risk Stratification of Patients Undergoing 
Major Noncardiac Surgery 
sRinfret. Carisi A. Polanczyk. Thomas H. Lee, Brigham and Women’s Hospital, 
Boston, Massachusetts, Centre Hospitalier de I’Universite de Montreal, Hopitsl Notre- 
Dame, Montreal, Quebec, Canada. 
Background: Despite preoperative stratification, additional information collected shortly 
after major non-cardiac (NC) surgery might help to reassess risk of major cardiac compli- 
cations (MCC) and guide therapy. The usefulness of a simple electrocardiogram (ECG) 
performed in the recovery room is unknown. 
Methods: Between 07169 and OZ94, perioperative data and outcomes were collected on 
4315 patients who underwent major NC procedures at Brigham end Woman’s Hospital. 
From this cohort, 3622 (63.9%) patients had an ECG performed in the recovery room. 
Results: Univariate analysis showed a higher incidence of MCC (myocardial infarction, 
pulmonary edema, ventricular fibrillation or primary cardiac arrest, and complete heart 
block) in patients with signs of ischemia (ST depression or elevation, or T wave abnor- 
malities) on the immediate postoperative (PO) ECG compared to those without ischemia 
(6.7 VS. 1.9%, p<O.OOl). Patients who presented signs of ischemia on PO ECG were 
older, more likely to be diabetic and treated with insulin, had a higher prevalence of coro- 
nary artery peripheral, or cerebrovascular disease, hypertension, congestive heart fail- 
